National Organization for Rare Disorders (NORD) Announces Kay Holcombe as New Board Chair and Dennis Jackman as New Member of its Board of Directors

Print Friendly, PDF & Email

WASHINGTONMay 18, 2021 /PRNewswire/ — The National Organization for Rare Disorders (NORD®) announced that during a recent Board of Directors meeting, Kay Holcombe was elected as Chair and Dennis Jackman joined as a new Board member. Each provides a dynamic and strong track record of leadership in public and private health sectors and in biotech innovation that will be instrumental in supporting NORD’s mission of helping the over 25 million Americans living with rare diseases.

Together with over 330 disease-specific member organizations and more than 15,000 Rare Action Network® advocates across all 50 states, and national and global partners, NORD is committed to the identification, treatment, and cure of rare diseases and disorders through programs of education, advocacy, research, and service. Since its founding nearly 40 years ago, NORD has expanded public knowledge of rare diseases and pioneered innovative research and other programs that are transforming science and the experience of living with a rare disease.

Click here to read the full article.